United States Of America to India: Mesalamine Import Trade Route

The United States Of America to India Mesalamine corridor is one of India's established pharmaceutical import routes from United States Of America, with 7 shipments documented worth a combined $36.5K USD. The route is dominated by AMSTERDAM PHARMA (APTEKA RX INC ), which alone accounts for roughly 68% of all import value, reflecting the consolidated nature of United States Of America's mesalamine export sector.

Across 6 active United States Of America suppliers, the average shipment value stands at $5.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with mesalamine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 29.3%, placing it at rank #17 among India's top mesalamine import origins globally.

On the Indian buyer side, key Indian importers include LAURUS LABS PRIVATE LIMITED, HETERO LABS LIMITED, BIOCON PHARMA LIMITED and 2 others. LAURUS LABS PRIVATE LIMITED is the single largest Indian importer with 2 shipments valued at $25.4K USD.

India's mesalamine imports from United States Of America are driven primarily by a handful of large-scale United States Of America manufacturers. AMSTERDAM PHARMA (APTEKA RX INC ) with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States Of America supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AMSTERDAM PHARMA (APTEKA RX INC ), GOOD HEALTH PHARMA SUPPLIES, XXW LXXE MXXICAXX (UXX) IXX — together account for 98% of total trade value on this route. The average shipment value of $5.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as mesalamine dr tablets 800mg (qty : 9 packs pack size : 180 tablets) and mesalamine delayed-release tablets800 mg (pack size: 180 in 1 bottle), suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States Of America supplier.

On the buying side, LAURUS LABS PRIVATE LIMITED is the largest importer with 2 shipments worth $25.4K USD — representing 70% of all mesalamine imports from United States Of America on this route.